Antiretroviral treatment for HIV infection and AIDS

被引:0
作者
Choi, Jun Yong [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, AIDS Res Inst, Seoul, South Korea
来源
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | 2024年 / 67卷 / 03期
关键词
Words; HIV; Acquired immunodeficiency syndrome; Therapeutics; Anti-retroviral agents; REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS-INFECTION; DRUG-RESISTANCE; THERAPY; SURVIVAL; ADULTS;
D O I
10.5124/jkma.2024.67.3.173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Antiretroviral therapy is the cornerstone treatment for people living with human immunodeficiency virus (HIV). Clinical practice guidelines for antiretroviral therapy have been developed. Current Concepts: After the introduction of zidovudine, more than 30 antiretroviral agents have been approved for the treatment of HIV infection. Since a controlled trial proved the efficacy and safety of combination antiretroviral therapy, virologic suppression, immune reconstitution, and long-term survival of people living with HIV have been achievable goals. Early antiretroviral treatment for all people living with HIV is an effective strategy to maintain individual health and prevent the transmission of HIV infection. Selecting an appropriate combination antiretroviral therapy requires careful consideration of various factors, including regimen characteristics, pretreatment viral load and CD4+ cell counts, comorbid conditions, and the anticipated level of compliance. Ongoing advances in antiretroviral treatment, such as the development of long -acting injectables and medications targeting multidrugresistant HIV, address challenges in the treatment of HIV infection. Discussion and Conclusion: Although cure of HIV infection is impossible with current antiretroviral treatment, HIV infection has become a chronic disease with long-term survival. Hence, clinicians should have knowledge of antiretroviral treatment guidelines.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 23 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]  
Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P729
[3]   Summary of 2021 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans [J].
Choi, Jun Yong ;
Wie, Seong-Heon ;
Kim, Nam Joong ;
Bang, Ji Hwan ;
Song, Joon Young ;
Shin, So Youn ;
Choi, Jae Phil ;
Chin, Bum Sik .
INFECTION AND CHEMOTHERAPY, 2021, 53 (03) :592-616
[4]  
clinicalinfo.hiv.gov, GUIDELINES USE ANTIR
[5]   Prevention of HIV-1 Infection with Early Antiretroviral Therapy [J].
Cohen, Myron S. ;
Chen, Ying Q. ;
McCauley, Marybeth ;
Gamble, Theresa ;
Hosseinipour, Mina C. ;
Kumarasamy, Nagalingeswaran ;
Hakim, James G. ;
Kumwenda, Johnstone ;
Grinsztejn, Beatriz ;
Pilotto, Jose H. S. ;
Godbole, Sheela V. ;
Mehendale, Sanjay ;
Chariyalertsak, Suwat ;
Santos, Breno R. ;
Mayer, Kenneth H. ;
Hoffman, Irving F. ;
Eshleman, Susan H. ;
Piwowar-Manning, Estelle ;
Wang, Lei ;
Makhema, Joseph ;
Mills, Lisa A. ;
de Bruyn, Guy ;
Sanne, Ian ;
Eron, Joseph ;
Gallant, Joel ;
Havlir, Diane ;
Swindells, Susan ;
Ribaudo, Heather ;
Elharrar, Vanessa ;
Burns, David ;
Taha, Taha E. ;
Nielsen-Saines, Karin ;
Celentano, David ;
Essex, Max ;
Fleming, Thomas R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06) :493-505
[6]  
Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001
[7]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733
[8]   Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy [J].
Hogg, RS ;
Yip, B ;
Chan, KJ ;
Wood, E ;
Craib, KJP ;
O'Shaughnessy, MV ;
Montaner, JSG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20) :2568-2577
[9]   Genotypic analysis of HIV-1 drug resistance at the limit of detection: Virus production without evolution in treated adults with undetectable HIV loads [J].
Kieffer, TL ;
Finucane, MM ;
Nettles, RE ;
Quinn, TC ;
Broman, KW ;
Ray, SC ;
Persaud, D ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08) :1452-1465
[10]   Epidemiology and clinical features of HIV infection/AIDS in Korea [J].
Kim, JM ;
Cho, GJ ;
Hong, SK ;
Chang, KH ;
Chung, JS ;
Choi, YH ;
Song, YG ;
Huh, A ;
Yeom, JS ;
Lee, KS ;
Choi, JY .
YONSEI MEDICAL JOURNAL, 2003, 44 (03) :363-370